ReviewThe Indian journal of medical research2026
Shigella and Guillain-Barré syndrome: Reconsidering an overlooked link.
Review in The Indian journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guillain-Barré Syndrome (GBS) is a rare autoimmune neurological disorder, mostly associated with preceding gastrointestinal or respiratory infections. Various bacterial and viral pathogens have been associated with GBS; Campylobacter jejuni being a well-established bacterial trigger. A few case reports and an outbreak of GBS wayback in 1976 also indicated an association of Shigella and GBS. Although Shigella primarily causes bacillary dysentery; however, it has been linked with neurological complications, including peripheral neuropathy. Shigella's substantial global burden, high endemicity in low- and middle-income countries (LMICs) with known neuroinvasive potential prompted us to explore its possible role in GBS outbreaks. This perspective discusses the recent GBS outbreak in India, the possible role of Shigella in GBS, and surveillance gaps for GBS in LMICs for rapid diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.